1 00:00:02,240 --> 00:00:03,400 - [Prof. Rohde] So my name is Holger Rohde. 2 00:00:03,400 --> 00:00:08,440 I'm working as a medical microbiologist at the University Medical Center in Hamburg. 3 00:00:08,440 --> 00:00:14,480 As a medical microbiologist, I'm primarily interested in improving diagnostics 4 00:00:14,480 --> 00:00:23,840 in the lab, and we have seen a lot of technical innovation that was mainly addressing in-lab problems 5 00:00:23,840 --> 00:00:28,490 and trying to optimize workflows within the lab. 6 00:00:28,490 --> 00:00:36,944 But right now we will see that these technologies also broaden the spectrum of interest, 7 00:00:36,944 --> 00:00:45,004 moving us to the question how the speed within the lab can be translating into speeding up time to result and 8 00:00:45,004 --> 00:00:49,854 time to optimize therapy of patients with infectious diseases. 9 00:00:49,854 --> 00:00:56,474 Looking at the market of ways to speed up susceptibility testing in the lab gives you an idea 10 00:00:56,474 --> 00:01:06,168 that there are a lot of different systems ranging from molecular diagnostics to phenotypic assays and having 11 00:01:06,168 --> 00:01:12,488 the...or being aware of the importance of emerging gram-negative, multi-resistant bacteria, 12 00:01:12,488 --> 00:01:21,078 we see the limitations of molecular assays, and therefore, we are convinced that the rapid 13 00:01:21,078 --> 00:01:25,198 phenotypic tests will make a difference. 14 00:01:25,198 --> 00:01:34,548 And the QuickMIC system, owing to the speed and short time to result has enabled 15 00:01:34,548 --> 00:01:42,928 us to completely change our workflows within the lab and change our way how we communicate results 16 00:01:42,928 --> 00:01:44,108 to the clinician. 17 00:01:44,108 --> 00:01:55,158 And we already see that this optimized way of diagnostics also changes treatment of patients and we 18 00:01:55,158 --> 00:02:03,414 hope to see that in the future these changes will also translate into lives being saved by these technologies. 19 00:02:03,414 --> 00:02:07,344 - [Dr. Malmberg] My name is Christer Malmberg. I am the chief scientist at Gradientech AB. 20 00:02:07,344 --> 00:02:12,304 We have identified some fundamental problems with the current AST technologies. 21 00:02:12,304 --> 00:02:18,314 They are too slow, they have too high variability, and there's also poor access to methods where they're 22 00:02:18,314 --> 00:02:20,584 needed the most, which is closer to the patient. 23 00:02:20,584 --> 00:02:26,843 So our aim is to introduce the fastest, most precise, and easy-to-use AST system on the market. 24 00:02:26,843 --> 00:02:31,065 So the QuickMIC system is a rapid, phenotypic, antibiotic susceptibility test, 25 00:02:31,065 --> 00:02:35,965 which means that we measure the susceptibility to antibiotics and you get a result, 26 00:02:35,965 --> 00:02:40,800 an MIC value which you can use when you want to know how to treat your patients. 27 00:02:40,800 --> 00:02:51,875 - For me, the most exciting thing is that microbiology will not only be a specialty that is focused 28 00:02:51,875 --> 00:02:59,115 on the lab, but a specialty that will be integrated into clinical pathways and pathways 29 00:02:59,115 --> 00:03:07,505 of patient management. And there, I see the future that will be significantly supported 30 00:03:07,505 --> 00:03:17,322 by systems like the QuickMIC system enabling us to get back to the bedside as a medical microbiologist.